11 Apr. 2019
BILANZ
Article in the Bilanz 17/2014 about BioVersys "Zeitmaschine fuer Antibiotika"
11 Apr. 2019
NEWSPAPER BAZ
Press clipping in the daily newspaper BaZ (Basler Zeitung) regarding the GSK collaboration.
11 Apr. 2019
BIOVERSYS TO DEVELOP PRECLINICAL CANDIDATES
BioVersys to develop preclinical candidates in tuberculosis with the support of the University of Lille and GlaxoSmithKline.BioVersys, avec le concour...
Recent Media Feeds
- Press Release - BioVersys hires new CDO, Dr. Glenn Dale
- Eurostars Funds IMPACT2 Press Release
- Dr. Gitzinger will be speaking at the UNCTAD/WHO event in Geneva, October 23rd, 2018 from 14:30-17:30 on Fostering investment in the development of new antibacterial treatments
- CARB-X welcomes UK Government and Bill & Melinda Gates Foundation as new partners
- BioVersys successfully closes Series A2 financing round
- October 20th, 2017; BioVersys and Marc Gitzinger were featured in the 3Sat news.
- BEAM Alliance fordert G20 Staaten zu mehr Unterstützung im Kampf gegen tödliche Superkeime auf
- Swiss biopharma BioVersys is collaborating with drug discovery and development CRO Aptuit on the discovery and development of new targets and drug candidates against Gram-negative bacteria, including drug-resistant strains. An existing BioVersys target will be included in the partnership.
- Press Release BEAM Alliance / Biocom AG
- Breaking through the Wall ... A Call for Concerted Action on AB Research and Development
